QuantiPath
PrivateLast Round
Seed Round
Apr 28, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
QuantiPath is a biotechnology company that operates a genetic testing technology platform intended for precise identification and quantification of Salmonella serovars.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Compliance, Quality Management
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QuantiPath Comparables
Compare QuantiPath with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neogen Corporation | 73% | |
| Bio-Rad Laboratories | 73% | |
| Thermo Fisher Scientific Inc. | 73% |
QuantiPath Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 28, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2026
Grew 30% QoQ, from 10 to 13 employees.
- Apr 28, 2026
Raised $1M in Seed Round funding.
QuantiPath Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about QuantiPath's valuation, stock price, and market status.
Is QuantiPath a public or private company?
QuantiPath is a private company.
What is the current stock price of QuantiPath?
QuantiPath is a private company with no public stock price. No recent secondary market data is available.
How much is QuantiPath worth (valuation)?
Valuation information for QuantiPath is not publicly available.
Can I buy QuantiPath stock?
QuantiPath shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was QuantiPath's last funding round?
QuantiPath's most recent funding round was Seed Round on April 28, 2026.
Who are the main investors in QuantiPath?
Investor information for QuantiPath is not publicly disclosed.
Will QuantiPath IPO soon?
No public IPO plans have been announced for QuantiPath.
How can I track QuantiPath secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor QuantiPath's secondary market activity and sign up for updates.